Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Motivating HIV+ Women: Risk Reduction and ART Adherence (KHARMA)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Marcia McDonnell Holstad, DSN, FNP-BC, Emory University
ClinicalTrials.gov Identifier:
NCT00253045
First received: November 14, 2005
Last updated: September 13, 2013
Last verified: September 2013